Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus–Infected Patients With or Without Human Immunodeficiency Virus Coinfection

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab094Source: DataRank Database

Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus–Infected Patients With or Without Human Immunodeficiency Virus Coinfection is a research paper published in The Journal of Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (49)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Thananya Jinato,Anchalee Avihingsanon ORCID,Sakkarin Chirapongsathorn ORCID,Supapon Cheevadhanarak,Intawat Nookaew ORCID

Live enrichment

PubMed:33598686 PMC:PMC8557699

Chulalongkorn University

Grant: RA62-033

Thailand Research Fund

Grant: RTA6280004

National Institutes of Health

Grant: P20GM125503

National Institutes of Health

Grant: 5P20GM125503-04

Center for Musculoskeletal Disease Research (CMDR)

Chulalongkorn University

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8557699

publisherhttp://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiab094/37055966/jiab094.pdf

publisherhttp://academic.oup.com/jid/article-pdf/224/8/1410/40978963/jiab094.pdf

https://doi.org/10.1093/infdis/jiab094

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557699

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansHepacivirusHepatitis CHIV InfectionsImidazolesBenzofuransQuinoxalinesDrug CombinationsAntiviral AgentsTreatment OutcomeViral LoadAdultAgedMiddle AgedFemaleMaleCoinfectionDrug-Related Side Effects and Adverse ReactionsDysbiosisGastrointestinal Microbiome

Keywords

16S rRNAHCVHIVGut MicrobiotaSvrDaasAdultMaleDrug-Related Side Effects and Adverse ReactionsCoinfectionImidazolesHIV InfectionsHepacivirusMiddle AgedViral LoadAntiviral AgentsHepatitis CGastrointestinal MicrobiomeDrug CombinationsTreatment OutcomeQuinoxalinesDysbiosisHumansFemaleAgedBenzofurans

Sustainable Development Goals

SDG 3: 3. Good health

Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus–Infected Patients With or Without Human Immunodeficiency Virus Coinfection

FAIR Checklist

Authors (8)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)